🚀 RECENT AI SUCCESS
Our AI successfully predicted the gap for $PUB.PA and executed a BUY strategy, securing a +9.52% net profit.
UPGRADE TO SEE LIVE SIGNALS
$4568.T
Daiichi Sankyo Co. Ltd.
FREE PREVIEW
📅 Next Earnings: Jul 31, 2026 🌙 Close🌐 Website🏛️ Tokyo Stock Exchange📁 Healthcare🏭 Drug Manufacturers – General
AVG HISTORICAL GAP0.45%
MAX GAP RECORD-5.35%
PREMIUM
AI ACCURACY RATE92.4%
Unlock AI Insights 🔓LAST 10 EARNINGS GAPS (%)
VOLATILITY & BIAS PROFILE
AVG VOLATILITY2.1%
Bullish Gaps
Bearish Gaps
Neutral
Intelligence Brief
Daiichi Sankyo Company, Limited manufactures and sells pharmaceutical products in Japan, the United States, Europe, and internationally. The company offers Enhertu to treat patients with HER2 positive and low breast cancer, HER2 positive gastric or gastroesophageal junction adenocarcinoma, and HER2 positive solid tumors; Turalio, an oral small molecule that targets colony stimulating factor 1 receptor, KIT proto-oncogene receptor tyrosine kinase,… Read full dossier
CURRENT AI SIGNAL
BULLISH STRONG
🔓 REVEAL SIGNAL